Raymond James Downgraded Four Medical Instruments & Supplies Stocks
Get Alerts RTIX Hot Sheet
Price: $3.14 --0%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Join SI Premium – FREE
Raymond James downgraded four Medical Instruments & Supplies stocks including:
Raymond James downgraded RTI Biologics (Nasdaq: RTIX) from Market Perform to Underperform, but share are ticking up 2.6%.
Merit Medical Systems (Nasdaq: MMSI) was downgraded from Strong Buy to Outperform. Shares are trading down approx. 1.7%.
Hospira (NYSE: HSP) was cut from Outperform to Market Perform. The stock is currently down 1%.
The biggest loser of the group is LCA-Vision (Nasdaq: LCAV), which was sliced from 'Outperform' to 'Market Perforn' Shares are now trading down ovre 6% to $5.57.
Raymond James downgraded RTI Biologics (Nasdaq: RTIX) from Market Perform to Underperform, but share are ticking up 2.6%.
Merit Medical Systems (Nasdaq: MMSI) was downgraded from Strong Buy to Outperform. Shares are trading down approx. 1.7%.
Hospira (NYSE: HSP) was cut from Outperform to Market Perform. The stock is currently down 1%.
The biggest loser of the group is LCA-Vision (Nasdaq: LCAV), which was sliced from 'Outperform' to 'Market Perforn' Shares are now trading down ovre 6% to $5.57.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
- Gerdes Energy Research Downgrades Equinor ASA (ADR) (EQNR) to Neutral
- RBC Capital Downgrades Temple & Webster Group Ltd (TPW:AU) to Sector Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share